Overview

The Study of MicroRNA Genomics of Blood Stasis Syndrome and of Coronary Heart Disease

Status:
Unknown status
Trial end date:
2014-12-01
Target enrollment:
0
Participant gender:
All
Summary
In this study, typical cases of blood stasis syndrome of coronary heart disease are selected, by using microRNA chip, cDNA microarray and other bioinformatics technologies to filter and verify related miRNA and its target gene of Coronary Heart disease. Meanwhile, intervene by Xuesaitong soft capsules to investigate related miRNA and its target gene of Coronary Heart disease.
Phase:
Phase 2
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Criteria
Inclusion Criteria:

- Clinical diagnosis of coronary angiography unstable angina

- Clinical diagnosis of unstable angina

- Age of 30 to 75 years old

- Not use thrombolysis, dilate coronary drugs within two weeks

- Tongue dark

- Sign the consent

Exclusion Criteria:

- Severe valvular heart disease

- Insulin-dependent diabetes

- mental disease

- Combined with severe liver, kidney, hematopoietic system disorder

- Patients with malignant tumors

- Pregnancy or breast-feeding women

- Recent history of trauma

- Drug allergy